HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY Vitamin E Reduces Monocyte Tissue Factor Expression in Cirrhotic Patients

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• The production and availability of tissue thromboplastin in cellular populations of whole blood exposed to various concentrations of endotoxin. An assay for detection of endotoxin.

  2009cited by this paper
• Enhanced expression of monocyte tissue factor in patients with liver cirrhosis

  1998cited by this paper
• Enhanced Lipid Peroxidation in Hepatic Cirrhosis

  1998cited by this paper
• 8-epi PGF2 alpha generation during coronary reperfusion. A potential quantitative marker of oxidant stress in vivo.

  1997cited by this paper
• Enhanced lipid peroxidation in patients positive for antiphospholipid antibodies.

  1997cited by this paper
• 8-Epi PGF2α Generation During Coronary Reperfusion

  1997cited by this paper
• The isoprostanes. Current knowledge and directions for future research.

  1996cited by this paper
• Modulation of oxidant stress in vivo in chronic cigarette smokers.

  1996cited by this paper
• The effects of alpha tocopherol supplementation on monocyte function. Decreased lipid oxidation, interleukin 1 beta secretion, and monocyte adhesion to endothelium.

  1996cited by this paper
• Association between High Values of D-dimer and Tissue-plasminogen Activator Activity and First Gastrointestinal Bleeding in Cirrhotic Patients

  1996cited by this paper
• Identification of the Major Urinary Metabolite of the F2-isoprostane 8-Iso-prostaglandin F2α in Humans*

  1996cited by this paper
• Generation of 8-epiprostaglandin F2alpha by human monocytes. Discriminate production by reactive oxygen species and prostaglandin endoperoxide synthase-2.

  1996cited by this paper
• Salicylates inhibit lipopolysaccharide-induced transcriptional activation of the tissue factor gene in human monocytic cells.

  1995cited by this paper
• LPS directly induces oxygen radical production in human monocytes via LPS binding protein and CD14

  1995cited by this paper
• Free radicals and phagocytic cells

  1995cited by this paper
• Association between low-grade disseminated intravascular coagulation and endotoxemia in patients with liver cirrhosis.

  1995cited by this paper
• Copper-induced tissue factor expression in human monocytic THP-1 cells and its inhibition by antioxidants.

  1995cited by this paper
• Monocyte tissue factor induction by lipopolysaccharide (LPS): dependence on LPS-binding protein and CD14, and inhibition by a recombinant fragment of bactericidal/permeability-increasing protein

  1994cited by this paper
• Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees.

  1994cited by this paper
• Induction of tissue factor-like activity in monocytes by anti-cardiolipin antibodies.

  1994cited by this paper
• Procoagulant and profibrinolytic activities of cryopreserved human monocytes.

  1994cited by this paper
• Formation of non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in plasma and low density lipoprotein exposed to oxidative stress in vitro.

  1994cited by this paper
• Hyperfibrinolysis increases the risk of gastrointestinal hemorrhage in patients with advanced cirrhosis

  1992cited by this paper
• Activation of the coagulation mechanism on tumor necrosis factor-stimulated cultured endothelial cells and their extracellular matrix. The role of flow and factor IX/IXa.

  1991cited by this paper
• Hemostasis and fibrinolysis in severe liver failure and their relation to hemorrhage

  1986cited by this paper
• Clinical significance of accelerated fibrinolysis in liver disease.

  1984cited by this paper
• Direct induction of tissue factor synthesis by endotoxin in human macrophages from diverse anatomical sites.

  1983cited by this paper
• Endotoxins and the pathogenesis of hepatic and gastrointestinal diseases.

  1982cited by this paper
• Enzymatic preparation of carboxyl oxygen-18 labeled prostaglandin F2 alpha and utility for quantitative mass spectrometry.

  1981cited by this paper
• Posttranscriptional Regulation of Macrophage Tissue Factor Expression by Antioxidants

  year unknowncited by this paper

• Vitamin E (α-Tocopherol): Emerging Clinical Role and Adverse Risks of Supplementation in Adults

  2025cites this paper
• Gut-derived low-grade endotoxaemia, atherothrombosis and cardiovascular disease

  2022cites this paper
• Arterial and venous thrombosis in coronavirus 2019 disease (Covid-19): relationship with mortality

  2021cites this paper
• Anticoagulation in patients with advanced liver disease: an open issue

  2020cites this paper
• Nutrition, Thrombosis, and Cardiovascular Disease

  2020cites this paper
• Reactive Oxygen Species in Venous Thrombosis

  2020cites this paper
• Vitamin E in Nonalcoholic Fatty Liver Disease

  2019cites this paper
• A Review on Clinical, Pathophysiological, and Diagnostic Hematological Features in Children With Liver Cirrhosis

  2019cites this paper
• Atherothrombosis and Oxidative Stress: Mechanisms and Management in Elderly

  2017cites this paper
• Classifying oxidative stress by F2-isoprostane levels across human diseases: A meta-analysis

  2017cites this paper
• Hepatocyte tissue factor contributes to the hypercoagulable state in a mouse model of chronic liver injury.

  2016cites this paper
• Tissue factor expression on blood monocytes in patients with hepatitis C virus-induced chronic liver disease

  2014cites this paper
• Vitamin E Serum Levels and Bleeding Risk in Patients Receiving Oral Anticoagulant Therapy: a Retrospective Cohort Study

  2013cites this paper
• Involvement of free radicals and oxidative stress in NAFLD/NASH

  2013cites this paper
• Cholesterol-adjusted vitamin E serum levels are associated with cardiovascular events in patients with non-valvular atrial fibrillation.

  2013cites this paper
• Oxidative Processes in Muscle Systems and Fresh Meat: Sources, Markers, and Remedies.

  2013cites this paper
• Niesteroidowe leki przeciwzapalne – fakty, mity i kontrowersje dotyczące ryzyka sercowo-naczyniowego oraz ryzyka powikłań ze strony przewodu pokarmowego

  2012cites this paper
• Asymmetric dimethylarginine (ADMA) determines the improvement of hepatic endothelial dysfunction by vitamin E in cirrhotic rats

  2012cites this paper
• Effects of Melatonin on The Tissue Factor Activities of Kidney, Heart and Brain in Experimental Renovascular Hypertension

  2012cites this paper
• Vitamin E inhibition on platelet procoagulant activity: involvement of aminophospholipid translocase activity.

  2011cites this paper
• Antioxidant supplements for liver diseases.

  2011cites this paper
• Clinical trial: low plasma cholesterol and oxidative stress predict rapid virological response to standard therapy with peginterferon and ribavirin in HCV patients

  2009cites this paper
• Experimental schistosomal hepatitis: protective effect of coenzyme-Q10 against the state of oxidative stress.

  2008cites this paper
• Biomarkers of exposure to vitamins A, C, and E and their relation to lipid and protein oxidation markers

  2008cites this paper
• Effects of Random Allocation to Vitamin E Supplementation on the Occurrence of Venous Thromboembolism: Report From the Women’s Health Study

  2007cites this paper
• Links between Nutrition, Drug Abuse, and the Metabolic Syndrome

  2006cites this paper
• Antioxidants and endothelium protection.

  2005cites this paper
• IZOPROSTANY - NOWE BIOMARKERY LIPIDOWEJ PEROKSYDACJI IN VIVO

  2004cites this paper
• Vitamin E supplementation increases polyunsaturated fatty acids of RBC membrane in HCV-infected patients.

  2004cites this paper
• Enhanced monocyte expression of tissue factor by oxidative stress in patients with antiphospholipid antibodies: effect of antioxidant treatment

  2003cites this paper
• Arachidonic acid in mononuclear cells and its clinical significance in HCV cirrhotic patients.

  2003cites this paper
• Vascular thrombogenicity induced by progressive LDL oxidation: protection by antioxidants

  2003cites this paper
• Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implications.

  2002cites this paper
• Enhanced monocyte tissue factor expression in hepatosplenic Schistosomiasis

  2002cites this paper
• Monocyte activation in alcoholic liver disease.

  2002cites this paper
• Habitual food intake and polyunsaturated fatty acid deficiency in liver cirrhosis.

  2002cites this paper
• The Coagulation System as a Target for the Treatment of Human Gliomas

  2002cites this paper
• Coagulation Disorders in Liver Disease

  2002cites this paper
• Oxidative stress-related molecules and liver fibrosis.

  2001cites this paper
• Vitamin E, Atherosclerosis and Thrombosis

  2001cites this paper
• Review Oxidative stress-related molecules and liver fibrosis

  2001cites this paper
• Isoprostanes: nouveaux marqueurs du stress oxydant. Aspects fondamentaux et cliniques

  2000cites this paper
• Oxidative stress and cardiovascular complications in diabetes: isoprostanes as new markers on an old paradigm.

  2000cites this paper
• Nutritional issues in cirrhosis and liver transplantation.

  1999cites this paper
• Anti-Aging Medicine LiteratureWatch

  1999cites this paper